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Chronic wounds such as Diabetic Foot Ulcers (DFU) and Leg Ulcers (LU) are increasingly prevalent and are a financial burden on the healthcare
system, a 2016 estimate of long lasting ulcers below the knee was 15 out of every 10,0000 people1. A 2010‐11 estimate calculated that approximately
£1 in every £140 of NHS spending is on foot ulcers or amputations each year2.
Wound dressings are a mainstay of treatment, however, the availability of a wide variety of dressings coupled with a lack of specific guidance
presents uncertainty. NICE NG19 states that clinicians are to use “dressings with the lowest acquisition cost appropriate to the clinical
circumstances”3. Cochrane reviews highlight the lack of robust studies with high levels of evidence surrounding several dressing types 4, 5.
To address the uncertainty regarding the use of dressings on chronic wounds, a modified Delphi methodology expert panel, involving two iterations
of email questionnaires, and one face to face meeting, was conducted to elicit expertise from a multidisciplinary group of experts.
Background
To gain consensus surrounding uncertainty in using dressings to improve wound outcomes.
• The modified process used for this study is shown below:
• The consensus threshold was 80%, and participants could vote yes or no against the statements, confirming or rejecting them. Unconfirmed












The ten clinical experts on the panel represented Nursing, Tissue Viability, Podiatry, Surgery and
Diabetology. Six technical experts representing Qualitative Research, Health Policy and Health
Economics, were present to advise on the process, but did not have voting rights on the statements.
Due to the large number of statements confirmed before the final round, as shown in the table to the
right, it was considered prudent to revisit comments on statements which had been confirmed with a
level of 80‐99%, in order to increase the level of consensus and ensure semantic clarity.
The final confirmed statements were used to create a larger consensus statement that had the



















































• This study aimed to address uncertainties in clinical practice by
developing a set of evidence‐based statements, validated by experts.
• The systematic literature review reported using PRISMA guidelines
and the use of a structured workbook to collect expert opinions allows
for repeatability and validation of the results.
• Given the culture of regulatory scrutiny, using a Delphi methodology
facilitated by an independent academic institution, protects the
legitimacy of scientific exchange between Clinical experts themselves,
and between the experts and the sponsoring manufacturers.
Limitations
• The binary voting system did not allow any ranking of the statements.
• As a result of working with opinions, a Delphi panel is subject to low
levels of evidence classifications.
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